About Cam Gallagher
Cam Gallagher is a director at Opus Genetics.
Form D filings name Cam Gallagher as a director at selectIon.
Cam Gallagher reports to the SEC as a director or officer of 3 public companies, including Zentalis Pharmaceuticals (ZNTL) and Sorrento Therapeutics (SRNEQ).
Cam Gallagher first appears on SEC filings in 2012.
Experience
This experience comes from SEC filings. The years are when the filings name Cam Gallagher in the role, so the role may have started earlier or lasted longer.
OI
Opus Genetics, Inc.
Director
2020 – 2026 · Public company (IRD)
ZI
Zentalis Pharmaceuticals, Inc.
President, Interim CFO and director
2020 – 2024 · Public company (ZNTL)
SI
Sorrento Therapeutics, Inc.
Director
2012 – 2014 · Public company (SRNEQ)
Key Colleagues at Startups
The people Cam Gallagher works with at each company, as listed on that company's latest Form D.
selectIon, Inc. · Form D, Sep 15, 2025
MF
Michael Foster
Director
AS
Antonius Schuh
Executive officer and director
DS
Don Scifres
Director
SZ
Stephen Zaniboni
Chief Financial Officer
MW
Mark Wiggins
Director